Withings brings scale with greatly expanded analysis functions

Withings has been offering body analysis scales for some time now, which not only measure weight and body composition but also values related to heart health and the condition of blood vessels. At the CES pre-event "CES Unveiled," the French manufacturer has now presented its upcoming model "Body Scan 2," which is said to capture over 60 clinically relevant biomarkers in 90 seconds. According to the manufacturer, these include cardiac output, arterial elasticity, blood sugar regulation, cellular health, and metabolic efficiency.

This makes the Body Scan 2 the world's first scientifically based "longevity station for home use." "Longevity" (English for long life) aims to slow down the aging process in order not only to live longer but above all to live healthier and more vital, and to maintain or improve quality of life in old age.

Visually, the Body Scan 2 differs from previous segment body analysis scales primarily in that the LCD (color) display has moved into the extendable handle. With two integrated buttons, users can also answer personalized questions about their lifestyle and are said to receive direct tips for a longer and healthier life. As with previous models, the scale has a built-in rechargeable battery, which is said to power the device for up to 15 months. According to the manufacturer, all health data is automatically synchronized via WLAN or Bluetooth with the Withings app on the user's smartphone. By complying with GDPR and HIPAA, as well as certifications according to ISO 27001 and ISO 27701, Withings claims to offer the highest possible security and data protection.

New Insights

According to Withings, the holistic assessment of cardiovascular and metabolic health enables concrete warnings and recommendations on how users can positively influence their long-term health. For example, the Body Scan 2 is said to be the first model for home use to issue a notification if there is a risk of hypertension. An Apple Watch also now has a hypertension warning, but detecting possible hypertension currently takes weeks – a fact that Withings founder and president Eric Carreel points out in the press release with general reference to wearables.

Furthermore, the new scale is the first model of its kind to offer an assessment of cardiac pump function using impedance cardiography (ICG) and an in-depth evaluation of cellular health, metabolic efficiency, and blood sugar regulation using ultra-high-frequency bioimpedance spectroscopy (BIS).

The thorough body scan, which reaches down to the cellular level, is made possible by the integration of medical technologies that were previously used exclusively in clinical settings, according to the manufacturer. The press release also indicates that an "exclusive AI detection model" is used in assessing user health – for example, with the new hypertension risk score. However, Withings does not provide more specific details.

Goal: Eternal Life

In longevity research, scientists investigate how the aging process can be biologically slowed down, for example, through cell repair and metabolism. The topic has gained public attention not least through the Netflix documentary "Don't Die – The Man Who Wants to Be Immortal" about the wealthy entrepreneur Bryan Johnson, who uses his body and fortune to defy aging and extend his life.

A central point is that Johnson tries to avoid a supposedly unhealthy lifestyle. This idea is also reflected in the press release for the new Withings scale, which states: "Body Scan 2 makes the insidious consequences of our current lifestyle visible long before noticeable symptoms indicate them."

Body Scan 2 is expected to be available from the second quarter of 2026 for €499.95 on withings.com and in retail.

(nij)